For patients with glioblastoma, the most common primary brain tumor in adults, immunotherapy is still struggling to overcome this lethal malignancy, says Michael Lim, director of the Brain Tumor Immunotherapy Program and coauthor of “Fire in the Smoke: Battling Brain Tumors.” Lim, M.D., talks about his career path, different types of tumors, and various approaches to defeating brain cancer.